PMID- 23791404
OWN - NLM
STAT- MEDLINE
DCOM- 20131217
LR  - 20211021
IS  - 1528-3933 (Electronic)
IS  - 1091-8531 (Print)
IS  - 1091-8531 (Linking)
VI  - 17
IP  - 3
DP  - 2013 Jun
TI  - Effects of oxygen on the development and severity of retinopathy of prematurity.
PG  - 229-34
LID - S1091-8531(13)00133-X [pii]
LID - 10.1016/j.jaapos.2012.12.155 [doi]
AB  - In 1942, when retinopathy of prematurity (ROP) first manifested as retrolental 
      fibroplasia, the technology to monitor or regulate oxygen did not exist, and a 
      fundus examination of preterm infants was not routinely performed. Supplemental, 
      uncontrolled oxygen at birth has since been found to cause retrolental 
      fibroplasia. At the same time, technological advances have made it possible to 
      regulate oxygen and detect early forms of ROP. Nevertheless, despite our better 
      understanding of ROP and ongoing investigations of supplemental therapeutic 
      oxygen, including recent clinical trials (Surfactant, Positive Airway Pressure, 
      Pulse Oximetry Randomized Trial [SUPPORT] and Benefits of Oxygen Saturation 
      Targeting [BOOST]), the best oxygen profiles to reduce ROP risk while optimizing 
      preterm infant health and development remain unknown. This article reviews major 
      studies on oxygen use in preterm infants and the effects on the development of 
      ROP.
CI  - Copyright (c) 2013 American Association for Pediatric Ophthalmology and Strabismus. 
      Published by Mosby, Inc. All rights reserved.
FAU - Hartnett, M Elizabeth
AU  - Hartnett ME
AD  - Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA. 
      me.hartnett@hsc.utah.edu
FAU - Lane, Robert H
AU  - Lane RH
LA  - eng
GR  - 1R01HL110002-01/HL/NHLBI NIH HHS/United States
GR  - R01 DK081756/DK/NIDDK NIH HHS/United States
GR  - R01 HL110002/HL/NHLBI NIH HHS/United States
GR  - P30 EY014800/EY/NEI NIH HHS/United States
GR  - R01 EY017011/EY/NEI NIH HHS/United States
GR  - R01EY017011/EY/NEI NIH HHS/United States
GR  - R01 EY015130/EY/NEI NIH HHS/United States
GR  - R01DK080558/DK/NIDDK NIH HHS/United States
GR  - R01EY015130/EY/NEI NIH HHS/United States
GR  - R01 DK080558/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Review
PL  - United States
TA  - J AAPOS
JT  - Journal of AAPOS : the official publication of the American Association for 
      Pediatric Ophthalmology and Strabismus
JID - 9710011
RN  - S88TT14065 (Oxygen)
SB  - IM
CIN - J AAPOS. 2013 Dec;17(6):650-2. PMID: 24200805
CIN - J AAPOS. 2013 Dec;17(6):652. PMID: 24215804
MH  - Bronchopulmonary Dysplasia/therapy
MH  - Humans
MH  - Infant, Low Birth Weight
MH  - Infant, Newborn
MH  - Infant, Premature/blood
MH  - Oxygen/*administration & dosage/blood
MH  - Oxygen Inhalation Therapy/*adverse effects
MH  - Respiratory Distress Syndrome, Newborn/therapy
MH  - Retinopathy of Prematurity/*etiology/*prevention & control
PMC - PMC3740273
MID - NIHMS487275
EDAT- 2013/06/26 06:00
MHDA- 2013/12/18 06:00
PMCR- 2014/06/01
CRDT- 2013/06/25 06:00
PHST- 2012/10/12 00:00 [received]
PHST- 2012/12/18 00:00 [revised]
PHST- 2012/12/30 00:00 [accepted]
PHST- 2013/06/25 06:00 [entrez]
PHST- 2013/06/26 06:00 [pubmed]
PHST- 2013/12/18 06:00 [medline]
PHST- 2014/06/01 00:00 [pmc-release]
AID - S1091-8531(13)00133-X [pii]
AID - 10.1016/j.jaapos.2012.12.155 [doi]
PST - ppublish
SO  - J AAPOS. 2013 Jun;17(3):229-34. doi: 10.1016/j.jaapos.2012.12.155.